patients

Safety and effectiveness of azithromycin in patients with COVID-19: an open-label randomised tria

/post-58

As no specific pharmacological treatment has been validated for use in coronavirus disease 2019 (COVID19), we aimed to assess the effectiveness of azithromycin (AZM) in these patients at a referral centre in Iran. An open-label, randomised controlled trial was conducted on patients with laboratoryconfirmed COVID-19.